Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. ACA
ACA logo

ACA Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Arcosa Inc (ACA) Today? Analysis, Price Targets, and 2026 Outlook.

No data

No data

No data

No data

Growth

Profitability

Efficiency

Wall Street analysts forecast ACA stock price to fall
1 Analyst Rating
Wall Street analysts forecast ACA stock price to fall
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 145.380
sliders
Low
115
Averages
115
High
115
Current: 145.380
sliders
Low
115
Averages
115
High
115
Texas Capital
Buy
to
Hold
downgrade
$150
AI Analysis
2026-06-23
Reason
Texas Capital
Price Target
$150
AI Analysis
2026-06-23
downgrade
Buy
to
Hold
Reason
Texas Capital downgraded Arcosa to Hold from Buy with a $150 price target citing the company's agreement to be acquired by CRH in an all-cash transaction for $150 per share.
Oppenheimer
initiated
$150
2026-05-28
Reason
Oppenheimer
Price Target
$150
2026-05-28
initiated
Reason
Oppenheimer assumed coverage of Arcosa with an Outperform rating and $150 price target. The firm sees a constructive environment for the infrastructure services and products sector. \"Profound\" growth and planning for data centers and complex facilities, along with broader electrification trends, are putting upward pressure on multi-year infrastructure capital plans, the analyst tells investors in a research note.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for ACA
Unlock Now

People Also Watch